ArticleBiomedical optics express2026
Label-free, multiphoton microscopy-based strategy for intraoperative grading of lung adenocarcinoma via quantitative extracellular matrix analysis.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung adenocarcinoma (LUAD) requires accurate subtyping for prognosis and treatment, yet conventional histopathology is time-consuming and subjective. This study applies label-free multiphoton microscopy (MPM) to quantify extracellular matrix remodeling, imaging collagen via SHG and elastin via TPEF in 88 specimens from 72 patients. We introduce a SHG/TPEF ratio (STR) system to assess tumor invasiveness. Results show progressive "fiber desertification," reduced fiber content, and decreased collagen alignment in high-grade LUAD subtypes. STR metrics strongly correlate with pathological grading and effectively distinguish aggressive patterns. This MPM-based framework enables rapid, objective intraoperative identification of high-grade LUAD, improving diagnostic precision and clinical decision-making.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.